Literature DB >> 21649643

Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes.

L Zhang, M H Fleischut, K Kohut, S Spencer, K Wong, Z K Stadler, N D Kauff, K Offit, M E Robson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21649643     DOI： 10.1111/j.1399-0004.2011.01691.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  3 in total

1.  Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.

Authors:  L Golmard; C Delnatte; A Laugé; V Moncoutier; C Lefol; K Abidallah; H Tenreiro; F Copigny; M Giraudeau; C Guy; C Barbaroux; G Amorim; A Briaux; V Guibert; J Tarabeux; S Caputo; A Collet; P Gesta; O Ingster; M-H Stern; E Rouleau; A de Pauw; M Gauthier-Villars; B Buecher; S Bézieau; D Stoppa-Lyonnet; C Houdayer
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

2.  Low-level constitutional mosaicism of a de novoBRCA1 gene mutation.

Authors:  E Friedman; N Efrat; L Soussan-Gutman; A Dvir; Y Kaplan; T Ekstein; K Nykamp; M Powers; M Rabideau; J Sorenson; S Topper
Journal:  Br J Cancer       Date:  2015-01-29       Impact factor: 7.640

3.  Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.

Authors:  Gabriela Es Felix; Camila Abe-Sandes; Taísa Mb Machado-Lopes; Thaís F Bomfim; Rodrigo Santa Cruz Guindalini; Vanessa Catarine Sar Santos; Lorena Meyer; Polyanna C Oliveira; João Cláudio Neiva; Roberto Meyer; Maura Romeo; Maria Betânia Toralles; Ivana Nascimento; Kiyoko Abe-Sandes
Journal:  Hum Genome Var       Date:  2014-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.